SHPH

Shuttle Pharmaceuticals Holdings, Inc. NASDAQ Listed Aug 31, 2022

Healthcare ·Pharmaceutical Preparations ·US · shuttlepharma.com

$0.71

Mkt Cap $755,859

52w Low $0.50 1.9% of range 52w High $11.25

50d MA $0.89 200d MA $2.25

P/E (TTM) -0.1x

EV/EBITDA -0.3x

P/B 0.5x

Debt/Equity 0.0x

ROE -519.9%

P/FCF -0.3x

RSI (14) —

ATR (14) —

Beta 0.72

50d MA $0.89

200d MA $2.25

Avg Volume 248.1K

Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and soft tissue sarcomas; and Doranidazole, an injectable hypoxic cell radiation sensitizer for treatment of pancreatic, lung, and liver cancers. The company was founded in 2012 and is based in Rockville, Maryland.

SIC Code

2834

CIK (SEC)

1757499

Phone

(240) 403-4212

401 PROFESSIONAL DRIVE · GAITHERSBURG, MD 20879 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Apr 1, 2026	AMC	—	-1.29	—	0.67	-0.0%	+12.9%	-1.8%	-0.0%	+0.7%	-3.3%	—
Nov 13, 2025	AMC	—	-1.05	—	2.31	-0.4%	+0.4%	-17.2%	+9.9%	-6.2%	-7.6%	—
Aug 12, 2025	AMC	—	-3.29	—	3.59	-1.4%	-1.4%	-1.1%	-5.1%	-1.2%	-4.3%	—
May 8, 2025	AMC	—	-7.50	—	6.75	+64.1%	-13.9%	-0.2%	-10.3%	+12.1%	-4.6%	—
Mar 20, 2025	AMC	—	-0.80	—	10.14	+5.0%	+3.8%	-6.3%	-3.4%	+6.0%	-2.3%	—
Nov 13, 2024	AMC	—	-39.75	—	27.75	-2.7%	-3.6%	-6.8%	-6.6%	-4.3%	+0.8%	—
Sep 3, 2024	AMC	—	-24.00	—	54.25	-27.6%	+9.2%	-8.4%	-24.9%	-11.7%	+0.7%	—
May 13, 2024	AMC	—	-20.00	—	80.00	+2.5%	+3.4%	-0.3%	+0.0%	-3.0%	+3.8%	—
Mar 21, 2024	AMC	—	-20.00	—	90.50	-0.6%	-1.1%	-4.2%	-0.9%	-1.2%	-3.3%	—
Nov 13, 2023	AMC	—	-0.11	—	100.50	+1.0%	-0.5%	+2.0%	+1.0%	-5.8%	+3.1%	—
Aug 14, 2023	AMC	—	-0.15	—	174.00	-1.7%	-5.7%	-3.7%	-1.3%	-3.5%	+1.0%	—
May 25, 2023	AMC	—	0.02	—	238.00	+21.0%	+0.8%	-9.2%	+1.9%	-0.1%	-3.2%	—

Data updated apr 27, 2026 1:12am · Source: massive.com